Strength TrainingNCT04048928
Maximal Strength Training in High-level Female Football Players
A study testing maximal strength training in people with Strength Training and Soccer, run by University of Tromso at 1 site in Norway.
Trial summary
Introduction: Maximal strength increments are reported to result in improvements in sprint speed and jump height in elite male football players. Although similar effects are expected in females, this is yet to be elucidated. Read more about this study
- Who is it for?
- Ages 15 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Strength Training, Soccer
- What is being tested?
- maximal strength training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 siteNorway
- Study dates
- 10 Feb 2018to 11 Apr 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 years and older
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- healthy and participating in one of the teams being invited for study
Who cannot join
- Players were only excluded if having injuries that made strength training, running and jumping unachievable.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Improvements in Maximal Strength Are Not Associated With Improvements in Sprint Time or Jump Height in High-level Female Football Players: A Cluster-randomized Controlled Trial
Introduction: Maximal strength increments are reported to result in improvements in sprint speed and jump height in elite male football players. Although similar effects are expected in females, this is yet to be elucidated. The aim of this study was to examine the effect of maximal strength training on sprint speed and jump height in high-level female football players.
Methods: Two female football teams were team-cluster-randomized to a training group (TG) performing maximal strength training (MST) twice a week for five weeks, or control group (CG) doing their regular pre-season preparations. The MST consisted of 3-4 sets of 4-6 repetitions at ≥85% of 1 repetition maximum (1RM) in a squat exercise. Sprint speed and jump height were assessed in 5-, 10- and 15 meter sprints and a counter-movement jump (CMJ) test, respectively. 19 participants in TG (18.3 ± 2.7 years) and 14 in CG (18.3 ± 2.4 years) completed pre- and posttests and were carried forward for final analyses.
Read the detailed description
In male football players, studies have reported a favorable effect on both 1RM, sprint and jumping performance following MST. Although females and males possess diverse levels of anabolic hormones, they do in general respond similarly after training interventions in most strength outcomes. However, there are reports of a larger relative increase in females compared to males when the same ST is applied.
In this cluster-randomized controlled trial, two football teams (playing at level 2 and 3 in Norway) was invited to participate. The study were conducted during the last part of the pre-season preparations, ending one week before first seasonal competition. The training group (TG) performed MST training carried out as free-barbell squats twice a week over five weeks in addition to the planned pre-season training, while the control group (CG) was instructed to perform their originally planned pre-season training.
The total sample comprised 46 players aged 15-26 years, where two separate football teams were cluster-randomized to either TG or CG. The two teams played at level two and three in Norway, where level two is a national league and level three a regional league in Northern Norway. Inclusion criteria was that the players perceived themselves as injury free and able to complete the strength training. Players were only excluded if having injuries that made strength training, running and jumping unachievable. The players carried out ̴ 6.5 h training per week with their team. Four players were injured, two did not complete the required amount of training, one withdrew due to time limitations and five withdrew without providing any reason resulting in 19 participants in TG and 15 in CG that completed both pre- and posttests, and were included in the analyses for training effect.
According to the declaration of Helsinki, all participants were fully informed of the potential benefits and risks of the study, both orally and written, before signing an informed consent. For participants under 16 years, both the players and their parents gave their written informed consent. The participants were fully informed of their rights to withdraw from the study at any time without providing any reason.
All testing and training sessions were conducted in an exercise training laboratory at Alfheim Stadium, Tromsø. Prior to the intervention, the players underwent baseline tests over two test days, with a 72 hour washout period to avoid any detrimental effects from the preceding test day: day 1) measurement of body mass and body height, 5-, 10- and 15m sprint time and a counter-movement jump (CMJ), day 2) 1RM in a free-barbell squat exercise with partial 90° knee angle range of motion (ROM).
Prior to the tests, the participants were asked to refrain from heavy training the preceding day, and to arrive in the laboratory well-hydrated. All tests and training sessions started in the afternoon, with the same general warm-up routine: 7 min of self-selected low intensity cycling on an ergometer bike (Pro/Trainer, Wattbike Ltd, Nottingham, UK) followed by 7 min low intensity running of self-selected speed on artificial grass.
On day 1, following the general warm-up and three 15 m strides on a sprinting field, a 15-m sprint test was carried out. Data were assessed in 5 m splits by photocells mounted to the floor and walls (ATU-X, IC control AB, Stockholm, Sweden) using single-beam electronic barriers. The within-subject coefficient of variation is 2% for this measurement. The surface consisted of artificial grass, and the players wore their own running shoes. The sprints started with the players in a static position placing their front foot 30 cm behind the starting line. A timer was triggered by the participant breaking the initial sensor. The rest interval between the single sprint trials was 180 seconds. The fastest sprint time of three trials was carried forward for further analyses.
Thereafter, the players rested for 5 minutes prior to performing the CMJ test. CMJ was assessed by a portable force platform, with a validity within 1 centimeter (2%) when compared with the gold standard mounted floor force platform, and a within-subject coefficient of variation of 2.8%. Force data were recorded by a software. This device records only the vertical ground reaction force at a sampling frequency of 1200 Hz and jump height is automatically calculated by software applying double integration of the force signal through Simpson's rule of integration. The players were instructed to keep their hands placed on the hips and the feet shoulder-width apart. Each player performed two trials with a ≥180 second rest between sets. The highest jump was carried forward for further analysis. Day 1 was ended with a familiarization trial for the squat exercise with low loads.
On day 2, the players returned to the laboratory for the assessment of maximal strength as 1RM. The session was initiated with the same general warm up routine as mentioned above. An Olympic barbell and a suitable rack was applied for testing of 1RM. The ~ 90° knee angle of each participant was measured during every repetition using a goniometer, and the players were given an orally "go" when being allowed to start the concentric phase of the lift. Prior to starting their 1RM attempts, the participants warmed up with 10 repetitions with a low load of - 50% 1RM (subjectively assessed by the instructor). The starting 1RM attempt was an initial acceptable load decided by the instructor. Each 1RM attempt was carried out by a single repetition, with increasing load of 5-10 kg until they failed to execute the 1RM attempt, which on average was five trials. Each attempt was interspaced by ≥180 s of rest. The within-subject coefficient of variation for squat 1RM is 2.9%.
The players attended supervised training in the laboratory twice a week for five weeks. The training session started with the general warm-up routine described above, before starting the strength training. The program consisted of 90° squats, carried out in the same way as in the 1RM test. The squat training was initiated with three sessions of three sets of six repetitions, followed by seven sessions of four sets of four repetitions. The repetitions were carried out with a slow eccentric movement followed by maximal mobilization in the concentric phase. 180 s of recovery was given between each set. The load was initially set at 85% of pre-test 1RM, which the participants increased with 2.5-10 kg if they could manage more than six or four repetitions, depending on their scheduled program, resulting in a consistent overload during the whole intervention. Weight lifted for each repetition was logged continuously during the study. Additionally, for ethical reasons, in order to avoid hamstring strains due to an anticipated large agonist-antagonist strength ratio following the intervention, three sets of six repetitions of the Nordic hamstring exercise were performed after the squat exercise for each session with a ≥180 s rest period between sets.
- Conditions
- Strength Training, Soccer
- Being tested
- maximal strength training
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
maximal strength trainingBehavioural
The training group (TG) performed MST training carried out as free-barbell squats twice a week over five weeks.
| Study group | Role | What they receive |
|---|---|---|
| Strength group | Experimental | Receives maximal strength training Receives: Behavioral: maximal strength training |
| Control group | No intervention | receives no active treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sprint time change
Sprint times measured at 5-, 10-, and 15 meter during a 15 meter sprint
Measured: 5 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Aug 2019
- Study start10 Feb 2018
- Primary completion11 Apr 2018
- Study completion11 Apr 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Strength TrainingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups is compared pre and post, where one is given treatment (strength training), and the other acts as control
- Masking
- None (open label)
- Enrolment
- 46 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Tromso
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Sigurd pedersen, MSc, Principal investigator, UiT, TheArctic University of Norway
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04048928
- Sponsor's protocol ID
- 59063 / 3
- Status last verified
- Aug 2019
- First submitted
- 30 Jul 2019
- Last updated
- 28 Aug 2019
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Data can be shared with researchers if needed
Publications
Pedersen S, Heitmann KA, Sagelv EH, Johansen D, Pettersen SA. Improved maximal strength is not associated with improvements in sprint time or jump height in high-level female football players: a clusterrendomized controlled trial. BMC Sports Sci Med Rehabil. 2019 Sep 17;11:20. doi: 10.1186/s13102-019-0133-9. eCollection 2019.
PubMed 31534773
Study at a glance
From the registry record, last updated by the sponsor on 28 Aug 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Improvements in Maximal Strength Are Not Associated With Improvements in Sprint Time or Jump Height in High-level Female Football Players: A Cluster-randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT04048928
- Acronym / sponsor ID
- 59063 / 3
- Conditions
- Strength Training, Soccer
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 46 participants (actual)
- Lead sponsor
- University of TromsoUniversity, hospital or other
- Study start
- 10 Feb 2018 (actual)
- Primary completion
- 11 Apr 2018 (actual)
- Study completion
- 11 Apr 2018 (actual)
- First posted
- 7 Aug 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction: Maximal strength increments are reported to result in improvements in sprint speed and jump height in elite male football players. Although similar effects are expected in females, this is yet to be elucidated. The aim of this study was to examine the effect of maximal strength training on sprint speed and jump height in high-level female football players.
Methods: Two female football teams were team-cluster-randomized to a training group (TG) performing maximal strength training (MST) twice a week for five weeks, or control group (CG) doing their regular pre-season preparations. The MST consisted of 3-4 sets of 4-6 repetitions at ≥85% of 1 repetition maximum (1RM) in a squat exercise. Sprint speed and jump height were assessed in 5-, 10- and 15 meter sprints and a counter-movement jump (CMJ) test, respectively. 19 participants in TG (18.3 ± 2.7 years) and 14 in CG (18.3 ± 2.4 years) completed pre- and posttests and were carried forward for final analyses.
Detailed description
In male football players, studies have reported a favorable effect on both 1RM, sprint and jumping performance following MST. Although females and males possess diverse levels of anabolic hormones, they do in general respond similarly after training interventions in most strength outcomes. However, there are reports of a larger relative increase in females compared to males when the same ST is applied.
In this cluster-randomized controlled trial, two football teams (playing at level 2 and 3 in Norway) was invited to participate. The study were conducted during the last part of the pre-season preparations, ending one week before first seasonal competition. The training group (TG) performed MST training carried out as free-barbell squats twice a week over five weeks in addition to the planned pre-season training, while the control group (CG) was instructed to perform their originally planned pre-season training.
The total sample comprised 46 players aged 15-26 years, where two separate football teams were cluster-randomized to either TG or CG. The two teams played at level two and three in Norway, where level two is a national league and level three a regional league in Northern Norway. Inclusion criteria was that the players perceived themselves as injury free and able to complete the strength training. Players were only excluded if having injuries that made strength training, running and jumping unachievable. The players carried out ̴ 6.5 h training per week with their team. Four players were injured, two did not complete the required amount of training, one withdrew due to time limitations and five withdrew without providing any reason resulting in 19 participants in TG and 15 in CG that completed both pre- and posttests, and were included in the analyses for training effect.
According to the declaration of Helsinki, all participants were fully informed of the potential benefits and risks of the study, both orally and written, before signing an informed consent. For participants under 16 years, both the players and their parents gave their written informed consent. The participants were fully informed of their rights to withdraw from the study at any time without providing any reason.
All testing and training sessions were conducted in an exercise training laboratory at Alfheim Stadium, Tromsø. Prior to the intervention, the players underwent baseline tests over two test days, with a 72 hour washout period to avoid any detrimental effects from the preceding test day: day 1) measurement of body mass and body height, 5-, 10- and 15m sprint time and a counter-movement jump (CMJ), day 2) 1RM in a free-barbell squat exercise with partial 90° knee angle range of motion (ROM).
Prior to the tests, the participants were asked to refrain from heavy training the preceding day, and to arrive in the laboratory well-hydrated. All tests and training sessions started in the afternoon, with the same general warm-up routine: 7 min of self-selected low intensity cycling on an ergometer bike (Pro/Trainer, Wattbike Ltd, Nottingham, UK) followed by 7 min low intensity running of self-selected speed on artificial grass.
On day 1, following the general warm-up and three 15 m strides on a sprinting field, a 15-m sprint test was carried out. Data were assessed in 5 m splits by photocells mounted to the floor and walls (ATU-X, IC control AB, Stockholm, Sweden) using single-beam electronic barriers. The within-subject coefficient of variation is 2% for this measurement. The surface consisted of artificial grass, and the players wore their own running shoes. The sprints started with the players in a static position placing their front foot 30 cm behind the starting line. A timer was triggered by the participant breaking the initial sensor. The rest interval between the single sprint trials was 180 seconds. The fastest sprint time of three trials was carried forward for further analyses.
Thereafter, the players rested for 5 minutes prior to performing the CMJ test. CMJ was assessed by a portable force platform, with a validity within 1 centimeter (2%) when compared with the gold standard mounted floor force platform, and a within-subject coefficient of variation of 2.8%. Force data were recorded by a software. This device records only the vertical ground reaction force at a sampling frequency of 1200 Hz and jump height is automatically calculated by software applying double integration of the force signal through Simpson's rule of integration. The players were instructed to keep their hands placed on the hips and the feet shoulder-width apart. Each player performed two trials with a ≥180 second rest between sets. The highest jump was carried forward for further analysis. Day 1 was ended with a familiarization trial for the squat exercise with low loads.
On day 2, the players returned to the laboratory for the assessment of maximal strength as 1RM. The session was initiated with the same general warm up routine as mentioned above. An Olympic barbell and a suitable rack was applied for testing of 1RM. The ~ 90° knee angle of each participant was measured during every repetition using a goniometer, and the players were given an orally "go" when being allowed to start the concentric phase of the lift. Prior to starting their 1RM attempts, the participants warmed up with 10 repetitions with a low load of - 50% 1RM (subjectively assessed by the instructor). The starting 1RM attempt was an initial acceptable load decided by the instructor. Each 1RM attempt was carried out by a single repetition, with increasing load of 5-10 kg until they failed to execute the 1RM attempt, which on average was five trials. Each attempt was interspaced by ≥180 s of rest. The within-subject coefficient of variation for squat 1RM is 2.9%.
The players attended supervised training in the laboratory twice a week for five weeks. The training session started with the general warm-up routine described above, before starting the strength training. The program consisted of 90° squats, carried out in the same way as in the 1RM test. The squat training was initiated with three sessions of three sets of six repetitions, followed by seven sessions of four sets of four repetitions. The repetitions were carried out with a slow eccentric movement followed by maximal mobilization in the concentric phase. 180 s of recovery was given between each set. The load was initially set at 85% of pre-test 1RM, which the participants increased with 2.5-10 kg if they could manage more than six or four repetitions, depending on their scheduled program, resulting in a consistent overload during the whole intervention. Weight lifted for each repetition was logged continuously during the study. Additionally, for ethical reasons, in order to avoid hamstring strains due to an anticipated large agonist-antagonist strength ratio following the intervention, three sets of six repetitions of the Nordic hamstring exercise were performed after the squat exercise for each session with a ≥180 s rest period between sets.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two groups is compared pre and post, where one is given treatment (strength training), and the other acts as control
| Arm | Type | Receives |
|---|---|---|
| Strength group | Experimental | Behavioral: maximal strength trainingReceives maximal strength training |
| Control group | No intervention | –receives no active treatment |
Who may qualify
- Ages
- 15 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- healthy and participating in one of the teams being invited for study
Key exclusion criteria (1 listed)
- Players were only excluded if having injuries that made strength training, running and jumping unachievable.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| maximal strength trainingThe training group (TG) performed MST training carried out as free-barbell squats twice a week over five weeks. | Behavioural | Strength group |
Primary outcome
Sprint time change
Time frame: 5 weeks
Sprint times measured at 5-, 10-, and 15 meter during a 15 meter sprint
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2019.
- Derived from this study: PubMed 31534773Pedersen S, Heitmann KA, Sagelv EH, Johansen D, Pettersen SA. Improved maximal strength is not associated with improvements in sprint time or jump height in high-level female football players: a clusterrendomized controlled trial. BMC Sports Sci Med Rehabil. 2019 Sep 17;11:20. doi: 10.1186/s13102-019-0133-9. eCollection 2019.
- Individual participant dataSharing planned: No. Data can be shared with researchers if needed
Related trials for Strength Training
Not yet recruiting
Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise
Treatment Adherence and Compliance, Resistance Exercise
Not yet recruiting
Effect of High Intensity Interval Training on Strength, Endurance and Flexibility
High Intensity Interval Training
Not yet recruiting
Exercise in Alzheimer's Disease: Functional Biomarkers
Alzheimer's Dementia (AD), Alzheimer Disease (AD)
Active, not recruiting
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
Hereditary Spastic Paraplegia
Recruiting
IMST for Dementia Risk Reduction
Systolic Blood Pressure, Blood Pressure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sigurd pedersen, MSc principal investigator
UiT, TheArctic University of Norway
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing maximal strength training in people with Strength Training and Soccer, run by University of Tromso at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sprint time change (time frame: 5 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04048928, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2019.